PPD (NASDAQ:PPD) CEO David S. Simmons acquired 40,000 shares of PPD stock in a transaction dated Monday, February 10th. The shares were bought at an average price of $32.25 per share, for a total transaction of $1,290,000.00.
PPD stock opened at $31.55 on Friday. PPD has a one year low of $29.56 and a one year high of $33.23.
PPD Company Profile
PPD, Inc provides drug development services to the biopharmaceutical industry worldwide. The company offers clinical development and laboratory services to the pharmaceutical, biotechnology, and medical device and government organizations, as well as other industry participants. It operates in two segments, Clinical Development Services and Laboratory Services.
Recommended Story: Is it Safe to Invest in Commodities?
Receive News & Ratings for PPD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PPD and related companies with MarketBeat.com's FREE daily email newsletter.